[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@MedUpdateOn1ine MedicalUpdateOnline
MedicalUpdateOnline posts on X about ge healthcare, eli lilly, sapien, $2413t the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX +3.50%
- X Month XXXXX -XX%
- X Months XXXXX +60%
- X Year XXXXXX -XXX%
Mentions: X #
- X Months XXX +33%
- X Year XXX +13%
Followers: XXXXX #
- X Week XXXXX +0.03%
- X Month XXXXX -XXXX%
- X Months XXXXX +2.30%
- X Year XXXXX +5.10%
CreatorRank: undefined #
Social Influence
Social category influence stocks
Social topic influence ge healthcare #46, eli lilly, sapien, $2413t, chronic
Top assets mentioned GE HealthCare Technologies Inc. Common Stock (GEHC) Eli Lilly and Company (LLY)
Top Social Posts
Top posts by engagements in the last XX hours
"New three-year data demonstrates sustained clinical benefits and established safety profile of Ingrezza (valbenazine) capsules for Huntington's disease chorea - Neurocrine Biosciences"
X Link 2025-10-10T01:00Z 6236 followers, XXX engagements
"Eli Lilly to share late-breaking and new Phase III results highlighting continued momentum in breast oncology at SABCS 2025"
X Link 2025-12-03T04:00Z 6234 followers, XXX engagements
"Genmab to highlight expanding clinical profile of epcoritamab at ASH 2025"
X Link 2025-11-11T04:00Z 6237 followers, XXX engagements
"Successful patient outcomes demonstrated with SAPIEN M3 and EVOQUE systems as mitral and tricuspid therapies - new data presented at TCT 2025 - Edwards Lifesciences"
X Link 2025-12-01T02:00Z 6236 followers, XX engagements
"GE HealthCare announces CE Mark for the new digital 4D SPECT/CT system StarGuide GX"
X Link 2025-12-03T02:00Z 6236 followers, XX engagements
"Rigel Pharma announces publication of final 5-year data on Rezlidhia (olutasidenib) in patients with R/R mIDH1 AML in the Journal of Hematology & Oncology"
X Link 2025-12-04T02:00Z 6237 followers, XX engagements
"GE HealthCare announces CE Mark for the Omni 128cm total body PET/CT system"
X Link 2025-12-08T02:00Z 6236 followers, XX engagements
"Sandoz launches denosumab biosimilars in Europe providing affordable treatment option for cancer-related bone disease and osteoporosis for millions of patients"
X Link 2025-12-10T02:00Z 6236 followers, XX engagements
"NICE (UK) positive for Nubeqa (darolutamide) with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer - Bayer"
X Link 2025-12-11T02:00Z 6237 followers, XX engagements
"FDA approves Tezspire (tezepelumab) for chronic rhinosinusitis with nasal polyps - Amgen+ AstraZeneca"
X Link 2025-12-12T02:00Z 6233 followers, XX engagements